They were seen as a better option for younger patients, who were likely to be more active and put more pressure on the joint.

Dr Neil McGuire MHRA’s clinical director of medical devices said: “Although the majority of patients with these metal on metal devices have well-functioning hips, it is known some may develop soft tissue reactions related to their implant.

“The clinical advice we have received indicates patients will likely have the best outcomes if these problems are detected early, monitored and treated if necessary.”

“If people have any questions about their hip replacement they should speak with their GP or implanting surgeon,” he said.

The previous recalls meant that patients with particular types of devices, and those suffering particular reactions had been subject to extra checks. The MRHA was unable to say how many patients this amounted to, but said that as many as half of patients with the devices may already be having some level of monitoring.

Today's decision was taken after tracking of thousands of case surgeons found the devices are still causing soft tissue reactions, many years after they were implanted.

It means that patients will be asked to undergo a series of checks - even if they are currently suffering from no symptoms at all.